▶ 調査レポート

抗原迅速検査のグローバル市場インサイト・予測(~2028年)

• 英文タイトル:Global Antigen Rapid Test Market Insights, Forecast to 2028

Global Antigen Rapid Test Market Insights, Forecast to 2028「抗原迅速検査のグローバル市場インサイト・予測(~2028年)」(市場規模、市場予測)調査レポートです。• レポートコード:QY2203B09221
• 出版社/出版日:QYResearch / 2022年3月25日
• レポート形態:英文、PDF、109ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療装置
• 販売価格(消費税別)
  Single User¥715,400 (USD4,900)▷ お問い合わせ
  Multi User¥1,073,100 (USD7,350)▷ お問い合わせ
  Enterprise License¥1,430,800 (USD9,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
新型コロナウイルス感染症のパンデミックにより、世界の抗原迅速検査の市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx%で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年に抗原迅速検査の世界市場のxxx%を占める「新型コロナウイルス感染症テスト関連迅速検査」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx%CAGRで成長すると予測されています。一方、「病院」セグメントは、この予測期間を通じてxxx%のCAGRに変更されます。
中国の抗原迅速検査の市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの抗原迅速検査市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx%であり、中国とヨーロッパはそれぞれxxx%とxxx%です。中国の割合は2028年にxxx%に達し、対象期間を通じてxxx%のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx%、xxx%、xxx%になる見通しです。ヨーロッパの抗原迅速検査市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx%になる見通しです。

抗原迅速検査のグローバル主要メーカーには、Abbott、Roche、BioMedomics、BD、Henry Schein、Safecare Bio-Tech、Mayo Clinic Laboratories、Chembio Diagnostics、Andon Health Co.,Ltd.、Ortho Clinical Diagnostics、Zhejiang Orient Gene Biotech、Oxford BioMedica、Affinity Biologicals、Epitope Diagnosticsなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx%の市場シェアを占めています。

抗原迅速検査市場は、種類と用途によって区分されます。世界の抗原迅速検査市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年~2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
新型コロナウイルス感染症テスト関連迅速検査、迅速連鎖球菌検査、迅速インフルエンザ診断検査(RIDT)、マラリア抗原検出検査

【用途別セグメント】
病院、科学研究、その他

【掲載地域】
北米:アメリカ、カナダ
ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋:日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米:メキシコ、ブラジル、アルゼンチン
中東・アフリカ:トルコ、サウジアラビア、UAE

【目次(一部)】

・調査の範囲
- 抗原迅速検査製品概要
- 種類別市場(新型コロナウイルス感染症テスト関連迅速検査、迅速連鎖球菌検査、迅速インフルエンザ診断検査(RIDT)、マラリア抗原検出検査)
- 用途別市場(病院、科学研究、その他)
- 調査の目的
・エグゼクティブサマリー
- 世界の抗原迅速検査販売量予測2017-2028
- 世界の抗原迅速検査売上予測2017-2028
- 抗原迅速検査の地域別販売量
- 抗原迅速検査の地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別抗原迅速検査販売量
- 主要メーカー別抗原迅速検査売上
- 主要メーカー別抗原迅速検査価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模(新型コロナウイルス感染症テスト関連迅速検査、迅速連鎖球菌検査、迅速インフルエンザ診断検査(RIDT)、マラリア抗原検出検査)
- 抗原迅速検査の種類別販売量
- 抗原迅速検査の種類別売上
- 抗原迅速検査の種類別価格
・用途別市場規模(病院、科学研究、その他)
- 抗原迅速検査の用途別販売量
- 抗原迅速検査の用途別売上
- 抗原迅速検査の用途別価格
・北米市場
- 北米の抗原迅速検査市場規模(種類別、用途別)
- 主要国別の抗原迅速検査市場規模(アメリカ、カナダ)
・ヨーロッパ市場
- ヨーロッパの抗原迅速検査市場規模(種類別、用途別)
- 主要国別の抗原迅速検査市場規模(ドイツ、フランス、イギリス、イタリア、ロシア)
・アジア太平洋市場
- アジア太平洋の抗原迅速検査市場規模(種類別、用途別)
- 主要国別の抗原迅速検査市場規模(日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア)
・中南米市場
- 中南米の抗原迅速検査市場規模(種類別、用途別)
- 主要国別の抗原迅速検査市場規模(メキシコ、ブラジル、アルゼンチン)
・中東・アフリカ市場
- 中東・アフリカの抗原迅速検査市場規模(種類別、用途別)
- 主要国別の抗原迅速検査市場規模(トルコ、サウジアラビア)
・企業情報
Abbott、Roche、BioMedomics、BD、Henry Schein、Safecare Bio-Tech、Mayo Clinic Laboratories、Chembio Diagnostics、Andon Health Co.,Ltd.、Ortho Clinical Diagnostics、Zhejiang Orient Gene Biotech、Oxford BioMedica、Affinity Biologicals、Epitope Diagnostics
・産業チェーン及び販売チャネル分析
- 抗原迅速検査の産業チェーン分析
- 抗原迅速検査の原材料
- 抗原迅速検査の生産プロセス
- 抗原迅速検査の販売及びマーケティング
- 抗原迅速検査の主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- 抗原迅速検査の産業動向
- 抗原迅速検査のマーケットドライバー
- 抗原迅速検査の課題
- 抗原迅速検査の阻害要因
・主な調査結果

Market Analysis and Insights: Global Antigen Rapid Test Market
Due to the COVID-19 pandemic, the global Antigen Rapid Test market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the review period. Fully considering the economic change by this health crisis, Covid-19-testing-related Rapid Tests accounting for % of the Antigen Rapid Test global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospitals segment is altered to an % CAGR throughout this forecast period.
China Antigen Rapid Test market size is valued at US$ million in 2021, while the US and Europe Antigen Rapid Test are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Antigen Rapid Test landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
The global key manufacturers of Antigen Rapid Test include Abbott, Roche, BioMedomics, BD, Henry Schein, Safecare Bio-Tech, Mayo Clinic Laboratories, Chembio Diagnostics and Andon Health Co.,Ltd., etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Antigen Rapid Test Scope and Segment
Antigen Rapid Test market is segmented by Type and by Application. Players, stakeholders, and other participants in the global Antigen Rapid Test market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Covid-19-testing-related Rapid Tests
Rapid Strep Tests
Rapid Influenza Diagnostic Tests (RIDT)
Malaria Antigen Detection Tests
Segment by Application
Hospitals
Scientific Research
Others
By Company
Abbott
Roche
BioMedomics
BD
Henry Schein
Safecare Bio-Tech
Mayo Clinic Laboratories
Chembio Diagnostics
Andon Health Co.,Ltd.
Ortho Clinical Diagnostics
Zhejiang Orient Gene Biotech
Oxford BioMedica
Affinity Biologicals
Epitope Diagnostics
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE

レポート目次

1 Study Coverage
1.1 Antigen Rapid Test Product Introduction
1.2 Market by Type
1.2.1 Global Antigen Rapid Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Covid-19-testing-related Rapid Tests
1.2.3 Rapid Strep Tests
1.2.4 Rapid Influenza Diagnostic Tests (RIDT)
1.2.5 Malaria Antigen Detection Tests
1.3 Market by Application
1.3.1 Global Antigen Rapid Test Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Scientific Research
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Antigen Rapid Test Sales Estimates and Forecasts 2017-2028
2.2 Global Antigen Rapid Test Revenue Estimates and Forecasts 2017-2028
2.3 Global Antigen Rapid Test Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Antigen Rapid Test Sales by Region
2.4.1 Global Antigen Rapid Test Sales by Region (2017-2022)
2.4.2 Global Sales Antigen Rapid Test by Region (2023-2028)
2.5 Global Antigen Rapid Test Revenue by Region
2.5.1 Global Antigen Rapid Test Revenue by Region (2017-2022)
2.5.2 Global Antigen Rapid Test Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Antigen Rapid Test Sales by Manufacturers
3.1.1 Global Top Antigen Rapid Test Manufacturers by Sales (2017-2022)
3.1.2 Global Antigen Rapid Test Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Antigen Rapid Test in 2021
3.2 Global Antigen Rapid Test Revenue by Manufacturers
3.2.1 Global Antigen Rapid Test Revenue by Manufacturers (2017-2022)
3.2.2 Global Antigen Rapid Test Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Antigen Rapid Test Revenue in 2021
3.3 Global Antigen Rapid Test Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Antigen Rapid Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Antigen Rapid Test Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Antigen Rapid Test Sales by Type
4.1.1 Global Antigen Rapid Test Historical Sales by Type (2017-2022)
4.1.2 Global Antigen Rapid Test Forecasted Sales by Type (2023-2028)
4.1.3 Global Antigen Rapid Test Sales Market Share by Type (2017-2028)
4.2 Global Antigen Rapid Test Revenue by Type
4.2.1 Global Antigen Rapid Test Historical Revenue by Type (2017-2022)
4.2.2 Global Antigen Rapid Test Forecasted Revenue by Type (2023-2028)
4.2.3 Global Antigen Rapid Test Revenue Market Share by Type (2017-2028)
4.3 Global Antigen Rapid Test Price by Type
4.3.1 Global Antigen Rapid Test Price by Type (2017-2022)
4.3.2 Global Antigen Rapid Test Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Antigen Rapid Test Sales by Application
5.1.1 Global Antigen Rapid Test Historical Sales by Application (2017-2022)
5.1.2 Global Antigen Rapid Test Forecasted Sales by Application (2023-2028)
5.1.3 Global Antigen Rapid Test Sales Market Share by Application (2017-2028)
5.2 Global Antigen Rapid Test Revenue by Application
5.2.1 Global Antigen Rapid Test Historical Revenue by Application (2017-2022)
5.2.2 Global Antigen Rapid Test Forecasted Revenue by Application (2023-2028)
5.2.3 Global Antigen Rapid Test Revenue Market Share by Application (2017-2028)
5.3 Global Antigen Rapid Test Price by Application
5.3.1 Global Antigen Rapid Test Price by Application (2017-2022)
5.3.2 Global Antigen Rapid Test Price Forecast by Application (2023-2028)
6 North America
6.1 North America Antigen Rapid Test Market Size by Type
6.1.1 North America Antigen Rapid Test Sales by Type (2017-2028)
6.1.2 North America Antigen Rapid Test Revenue by Type (2017-2028)
6.2 North America Antigen Rapid Test Market Size by Application
6.2.1 North America Antigen Rapid Test Sales by Application (2017-2028)
6.2.2 North America Antigen Rapid Test Revenue by Application (2017-2028)
6.3 North America Antigen Rapid Test Market Size by Country
6.3.1 North America Antigen Rapid Test Sales by Country (2017-2028)
6.3.2 North America Antigen Rapid Test Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Antigen Rapid Test Market Size by Type
7.1.1 Europe Antigen Rapid Test Sales by Type (2017-2028)
7.1.2 Europe Antigen Rapid Test Revenue by Type (2017-2028)
7.2 Europe Antigen Rapid Test Market Size by Application
7.2.1 Europe Antigen Rapid Test Sales by Application (2017-2028)
7.2.2 Europe Antigen Rapid Test Revenue by Application (2017-2028)
7.3 Europe Antigen Rapid Test Market Size by Country
7.3.1 Europe Antigen Rapid Test Sales by Country (2017-2028)
7.3.2 Europe Antigen Rapid Test Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Antigen Rapid Test Market Size by Type
8.1.1 Asia Pacific Antigen Rapid Test Sales by Type (2017-2028)
8.1.2 Asia Pacific Antigen Rapid Test Revenue by Type (2017-2028)
8.2 Asia Pacific Antigen Rapid Test Market Size by Application
8.2.1 Asia Pacific Antigen Rapid Test Sales by Application (2017-2028)
8.2.2 Asia Pacific Antigen Rapid Test Revenue by Application (2017-2028)
8.3 Asia Pacific Antigen Rapid Test Market Size by Region
8.3.1 Asia Pacific Antigen Rapid Test Sales by Region (2017-2028)
8.3.2 Asia Pacific Antigen Rapid Test Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Antigen Rapid Test Market Size by Type
9.1.1 Latin America Antigen Rapid Test Sales by Type (2017-2028)
9.1.2 Latin America Antigen Rapid Test Revenue by Type (2017-2028)
9.2 Latin America Antigen Rapid Test Market Size by Application
9.2.1 Latin America Antigen Rapid Test Sales by Application (2017-2028)
9.2.2 Latin America Antigen Rapid Test Revenue by Application (2017-2028)
9.3 Latin America Antigen Rapid Test Market Size by Country
9.3.1 Latin America Antigen Rapid Test Sales by Country (2017-2028)
9.3.2 Latin America Antigen Rapid Test Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Antigen Rapid Test Market Size by Type
10.1.1 Middle East and Africa Antigen Rapid Test Sales by Type (2017-2028)
10.1.2 Middle East and Africa Antigen Rapid Test Revenue by Type (2017-2028)
10.2 Middle East and Africa Antigen Rapid Test Market Size by Application
10.2.1 Middle East and Africa Antigen Rapid Test Sales by Application (2017-2028)
10.2.2 Middle East and Africa Antigen Rapid Test Revenue by Application (2017-2028)
10.3 Middle East and Africa Antigen Rapid Test Market Size by Country
10.3.1 Middle East and Africa Antigen Rapid Test Sales by Country (2017-2028)
10.3.2 Middle East and Africa Antigen Rapid Test Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Abbott
11.1.1 Abbott Corporation Information
11.1.2 Abbott Overview
11.1.3 Abbott Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Abbott Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Abbott Recent Developments
11.2 Roche
11.2.1 Roche Corporation Information
11.2.2 Roche Overview
11.2.3 Roche Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Roche Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Roche Recent Developments
11.3 BioMedomics
11.3.1 BioMedomics Corporation Information
11.3.2 BioMedomics Overview
11.3.3 BioMedomics Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 BioMedomics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 BioMedomics Recent Developments
11.4 BD
11.4.1 BD Corporation Information
11.4.2 BD Overview
11.4.3 BD Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 BD Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 BD Recent Developments
11.5 Henry Schein
11.5.1 Henry Schein Corporation Information
11.5.2 Henry Schein Overview
11.5.3 Henry Schein Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Henry Schein Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Henry Schein Recent Developments
11.6 Safecare Bio-Tech
11.6.1 Safecare Bio-Tech Corporation Information
11.6.2 Safecare Bio-Tech Overview
11.6.3 Safecare Bio-Tech Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Safecare Bio-Tech Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Safecare Bio-Tech Recent Developments
11.7 Mayo Clinic Laboratories
11.7.1 Mayo Clinic Laboratories Corporation Information
11.7.2 Mayo Clinic Laboratories Overview
11.7.3 Mayo Clinic Laboratories Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Mayo Clinic Laboratories Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Mayo Clinic Laboratories Recent Developments
11.8 Chembio Diagnostics
11.8.1 Chembio Diagnostics Corporation Information
11.8.2 Chembio Diagnostics Overview
11.8.3 Chembio Diagnostics Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Chembio Diagnostics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Chembio Diagnostics Recent Developments
11.9 Andon Health Co.,Ltd.
11.9.1 Andon Health Co.,Ltd. Corporation Information
11.9.2 Andon Health Co.,Ltd. Overview
11.9.3 Andon Health Co.,Ltd. Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Andon Health Co.,Ltd. Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Andon Health Co.,Ltd. Recent Developments
11.10 Ortho Clinical Diagnostics
11.10.1 Ortho Clinical Diagnostics Corporation Information
11.10.2 Ortho Clinical Diagnostics Overview
11.10.3 Ortho Clinical Diagnostics Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Ortho Clinical Diagnostics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Ortho Clinical Diagnostics Recent Developments
11.11 Zhejiang Orient Gene Biotech
11.11.1 Zhejiang Orient Gene Biotech Corporation Information
11.11.2 Zhejiang Orient Gene Biotech Overview
11.11.3 Zhejiang Orient Gene Biotech Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Zhejiang Orient Gene Biotech Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Zhejiang Orient Gene Biotech Recent Developments
11.12 Oxford BioMedica
11.12.1 Oxford BioMedica Corporation Information
11.12.2 Oxford BioMedica Overview
11.12.3 Oxford BioMedica Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Oxford BioMedica Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Oxford BioMedica Recent Developments
11.13 Affinity Biologicals
11.13.1 Affinity Biologicals Corporation Information
11.13.2 Affinity Biologicals Overview
11.13.3 Affinity Biologicals Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Affinity Biologicals Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Affinity Biologicals Recent Developments
11.14 Epitope Diagnostics
11.14.1 Epitope Diagnostics Corporation Information
11.14.2 Epitope Diagnostics Overview
11.14.3 Epitope Diagnostics Antigen Rapid Test Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Epitope Diagnostics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Epitope Diagnostics Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Antigen Rapid Test Industry Chain Analysis
12.2 Antigen Rapid Test Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Antigen Rapid Test Production Mode & Process
12.4 Antigen Rapid Test Sales and Marketing
12.4.1 Antigen Rapid Test Sales Channels
12.4.2 Antigen Rapid Test Distributors
12.5 Antigen Rapid Test Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Antigen Rapid Test Industry Trends
13.2 Antigen Rapid Test Market Drivers
13.3 Antigen Rapid Test Market Challenges
13.4 Antigen Rapid Test Market Restraints
14 Key Findings in The Global Antigen Rapid Test Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Antigen Rapid Test Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Covid-19-testing-related Rapid Tests
Table 3. Major Manufacturers of Rapid Strep Tests
Table 4. Major Manufacturers of Rapid Influenza Diagnostic Tests (RIDT)
Table 5. Major Manufacturers of Malaria Antigen Detection Tests
Table 6. Global Antigen Rapid Test Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Antigen Rapid Test Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Antigen Rapid Test Sales by Region (2017-2022) & (M Units)
Table 9. Global Antigen Rapid Test Sales Market Share by Region (2017-2022)
Table 10. Global Antigen Rapid Test Sales by Region (2023-2028) & (M Units)
Table 11. Global Antigen Rapid Test Sales Market Share by Region (2023-2028)
Table 12. Global Antigen Rapid Test Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Antigen Rapid Test Revenue Market Share by Region (2017-2022)
Table 14. Global Antigen Rapid Test Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Antigen Rapid Test Revenue Market Share by Region (2023-2028)
Table 16. Global Antigen Rapid Test Sales by Manufacturers (2017-2022) & (M Units)
Table 17. Global Antigen Rapid Test Sales Share by Manufacturers (2017-2022)
Table 18. Global Antigen Rapid Test Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Antigen Rapid Test Revenue Share by Manufacturers (2017-2022)
Table 20. Antigen Rapid Test Price by Manufacturers (2017-2022) &(US$/Unit)
Table 21. Global Antigen Rapid Test Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Antigen Rapid Test by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antigen Rapid Test as of 2021)
Table 23. Antigen Rapid Test Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Antigen Rapid Test Product Offered
Table 25. Date of Manufacturers Enter into Antigen Rapid Test Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Antigen Rapid Test Sales by Type (2017-2022) & (M Units)
Table 28. Global Antigen Rapid Test Sales by Type (2023-2028) & (M Units)
Table 29. Global Antigen Rapid Test Sales Share by Type (2017-2022)
Table 30. Global Antigen Rapid Test Sales Share by Type (2023-2028)
Table 31. Global Antigen Rapid Test Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Antigen Rapid Test Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Antigen Rapid Test Revenue Share by Type (2017-2022)
Table 34. Global Antigen Rapid Test Revenue Share by Type (2023-2028)
Table 35. Antigen Rapid Test Price by Type (2017-2022) & (US$/Unit)
Table 36. Global Antigen Rapid Test Price Forecast by Type (2023-2028) & (US$/Unit)
Table 37. Global Antigen Rapid Test Sales by Application (2017-2022) & (M Units)
Table 38. Global Antigen Rapid Test Sales by Application (2023-2028) & (M Units)
Table 39. Global Antigen Rapid Test Sales Share by Application (2017-2022)
Table 40. Global Antigen Rapid Test Sales Share by Application (2023-2028)
Table 41. Global Antigen Rapid Test Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Antigen Rapid Test Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Antigen Rapid Test Revenue Share by Application (2017-2022)
Table 44. Global Antigen Rapid Test Revenue Share by Application (2023-2028)
Table 45. Antigen Rapid Test Price by Application (2017-2022) & (US$/Unit)
Table 46. Global Antigen Rapid Test Price Forecast by Application (2023-2028) & (US$/Unit)
Table 47. North America Antigen Rapid Test Sales by Type (2017-2022) & (M Units)
Table 48. North America Antigen Rapid Test Sales by Type (2023-2028) & (M Units)
Table 49. North America Antigen Rapid Test Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Antigen Rapid Test Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Antigen Rapid Test Sales by Application (2017-2022) & (M Units)
Table 52. North America Antigen Rapid Test Sales by Application (2023-2028) & (M Units)
Table 53. North America Antigen Rapid Test Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Antigen Rapid Test Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Antigen Rapid Test Sales by Country (2017-2022) & (M Units)
Table 56. North America Antigen Rapid Test Sales by Country (2023-2028) & (M Units)
Table 57. North America Antigen Rapid Test Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Antigen Rapid Test Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Antigen Rapid Test Sales by Type (2017-2022) & (M Units)
Table 60. Europe Antigen Rapid Test Sales by Type (2023-2028) & (M Units)
Table 61. Europe Antigen Rapid Test Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Antigen Rapid Test Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Antigen Rapid Test Sales by Application (2017-2022) & (M Units)
Table 64. Europe Antigen Rapid Test Sales by Application (2023-2028) & (M Units)
Table 65. Europe Antigen Rapid Test Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Antigen Rapid Test Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Antigen Rapid Test Sales by Country (2017-2022) & (M Units)
Table 68. Europe Antigen Rapid Test Sales by Country (2023-2028) & (M Units)
Table 69. Europe Antigen Rapid Test Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Antigen Rapid Test Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Antigen Rapid Test Sales by Type (2017-2022) & (M Units)
Table 72. Asia Pacific Antigen Rapid Test Sales by Type (2023-2028) & (M Units)
Table 73. Asia Pacific Antigen Rapid Test Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Antigen Rapid Test Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Antigen Rapid Test Sales by Application (2017-2022) & (M Units)
Table 76. Asia Pacific Antigen Rapid Test Sales by Application (2023-2028) & (M Units)
Table 77. Asia Pacific Antigen Rapid Test Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Antigen Rapid Test Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Antigen Rapid Test Sales by Region (2017-2022) & (M Units)
Table 80. Asia Pacific Antigen Rapid Test Sales by Region (2023-2028) & (M Units)
Table 81. Asia Pacific Antigen Rapid Test Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Antigen Rapid Test Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Antigen Rapid Test Sales by Type (2017-2022) & (M Units)
Table 84. Latin America Antigen Rapid Test Sales by Type (2023-2028) & (M Units)
Table 85. Latin America Antigen Rapid Test Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Antigen Rapid Test Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Antigen Rapid Test Sales by Application (2017-2022) & (M Units)
Table 88. Latin America Antigen Rapid Test Sales by Application (2023-2028) & (M Units)
Table 89. Latin America Antigen Rapid Test Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Antigen Rapid Test Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Antigen Rapid Test Sales by Country (2017-2022) & (M Units)
Table 92. Latin America Antigen Rapid Test Sales by Country (2023-2028) & (M Units)
Table 93. Latin America Antigen Rapid Test Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Antigen Rapid Test Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Antigen Rapid Test Sales by Type (2017-2022) & (M Units)
Table 96. Middle East and Africa Antigen Rapid Test Sales by Type (2023-2028) & (M Units)
Table 97. Middle East and Africa Antigen Rapid Test Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Antigen Rapid Test Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Antigen Rapid Test Sales by Application (2017-2022) & (M Units)
Table 100. Middle East and Africa Antigen Rapid Test Sales by Application (2023-2028) & (M Units)
Table 101. Middle East and Africa Antigen Rapid Test Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Antigen Rapid Test Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Antigen Rapid Test Sales by Country (2017-2022) & (M Units)
Table 104. Middle East and Africa Antigen Rapid Test Sales by Country (2023-2028) & (M Units)
Table 105. Middle East and Africa Antigen Rapid Test Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Antigen Rapid Test Revenue by Country (2023-2028) & (US$ Million)
Table 107. Abbott Corporation Information
Table 108. Abbott Description and Major Businesses
Table 109. Abbott Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 110. Abbott Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Abbott Recent Developments
Table 112. Roche Corporation Information
Table 113. Roche Description and Major Businesses
Table 114. Roche Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 115. Roche Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Roche Recent Developments
Table 117. BioMedomics Corporation Information
Table 118. BioMedomics Description and Major Businesses
Table 119. BioMedomics Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 120. BioMedomics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. BioMedomics Recent Developments
Table 122. BD Corporation Information
Table 123. BD Description and Major Businesses
Table 124. BD Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 125. BD Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. BD Recent Developments
Table 127. Henry Schein Corporation Information
Table 128. Henry Schein Description and Major Businesses
Table 129. Henry Schein Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 130. Henry Schein Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Henry Schein Recent Developments
Table 132. Safecare Bio-Tech Corporation Information
Table 133. Safecare Bio-Tech Description and Major Businesses
Table 134. Safecare Bio-Tech Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 135. Safecare Bio-Tech Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Safecare Bio-Tech Recent Developments
Table 137. Mayo Clinic Laboratories Corporation Information
Table 138. Mayo Clinic Laboratories Description and Major Businesses
Table 139. Mayo Clinic Laboratories Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 140. Mayo Clinic Laboratories Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Mayo Clinic Laboratories Recent Developments
Table 142. Chembio Diagnostics Corporation Information
Table 143. Chembio Diagnostics Description and Major Businesses
Table 144. Chembio Diagnostics Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 145. Chembio Diagnostics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Chembio Diagnostics Recent Developments
Table 147. Andon Health Co.,Ltd. Corporation Information
Table 148. Andon Health Co.,Ltd. Description and Major Businesses
Table 149. Andon Health Co.,Ltd. Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 150. Andon Health Co.,Ltd. Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Andon Health Co.,Ltd. Recent Developments
Table 152. Ortho Clinical Diagnostics Corporation Information
Table 153. Ortho Clinical Diagnostics Description and Major Businesses
Table 154. Ortho Clinical Diagnostics Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 155. Ortho Clinical Diagnostics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Ortho Clinical Diagnostics Recent Developments
Table 157. Zhejiang Orient Gene Biotech Corporation Information
Table 158. Zhejiang Orient Gene Biotech Description and Major Businesses
Table 159. Zhejiang Orient Gene Biotech Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 160. Zhejiang Orient Gene Biotech Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Zhejiang Orient Gene Biotech Recent Developments
Table 162. Oxford BioMedica Corporation Information
Table 163. Oxford BioMedica Description and Major Businesses
Table 164. Oxford BioMedica Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 165. Oxford BioMedica Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Oxford BioMedica Recent Developments
Table 167. Affinity Biologicals Corporation Information
Table 168. Affinity Biologicals Description and Major Businesses
Table 169. Affinity Biologicals Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 170. Affinity Biologicals Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Affinity Biologicals Recent Developments
Table 172. Epitope Diagnostics Corporation Information
Table 173. Epitope Diagnostics Description and Major Businesses
Table 174. Epitope Diagnostics Antigen Rapid Test Sales (M Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 175. Epitope Diagnostics Antigen Rapid Test Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Epitope Diagnostics Recent Developments
Table 177. Key Raw Materials Lists
Table 178. Raw Materials Key Suppliers Lists
Table 179. Antigen Rapid Test Distributors List
Table 180. Antigen Rapid Test Customers List
Table 181. Antigen Rapid Test Market Trends
Table 182. Antigen Rapid Test Market Drivers
Table 183. Antigen Rapid Test Market Challenges
Table 184. Antigen Rapid Test Market Restraints
Table 185. Research Programs/Design for This Report
Table 186. Key Data Information from Secondary Sources
Table 187. Key Data Information from Primary Sources
List of Figures
Figure 1. Antigen Rapid Test Product Picture
Figure 3. Global Antigen Rapid Test Market Share by Type in 2021 & 2028
Figure 3. Covid-19-testing-related Rapid Tests Product Picture
Figure 4. Rapid Strep Tests Product Picture
Figure 5. Rapid Influenza Diagnostic Tests (RIDT) Product Picture
Figure 6. Malaria Antigen Detection Tests Product Picture
Figure 7. Global Antigen Rapid Test Market Share by Application in 2021 & 2028
Figure 8. Hospitals
Figure 9. Scientific Research
Figure 10. Others
Figure 11. Antigen Rapid Test Report Years Considered
Figure 12. Global Antigen Rapid Test Sales 2017-2028 (M Units)
Figure 13. Global Antigen Rapid Test Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Antigen Rapid Test Revenue 2017-2028 (US$ Million)
Figure 15. Global Antigen Rapid Test Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 16. Global Antigen Rapid Test Sales Market Share by Region (2017-2022)
Figure 17. Global Antigen Rapid Test Sales Market Share by Region (2023-2028)
Figure 18. North America Antigen Rapid Test Sales YoY (2017-2028) & (M Units)
Figure 19. North America Antigen Rapid Test Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Europe Antigen Rapid Test Sales YoY (2017-2028) & (M Units)
Figure 21. Europe Antigen Rapid Test Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Asia-Pacific Antigen Rapid Test Sales YoY (2017-2028) & (M Units)
Figure 23. Asia-Pacific Antigen Rapid Test Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Latin America Antigen Rapid Test Sales YoY (2017-2028) & (M Units)
Figure 25. Latin America Antigen Rapid Test Revenue YoY (2017-2028) & (US$ Million)
Figure 26. Middle East & Africa Antigen Rapid Test Sales YoY (2017-2028) & (M Units)
Figure 27. Middle East & Africa Antigen Rapid Test Revenue YoY (2017-2028) & (US$ Million)
Figure 28. The Antigen Rapid Test Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 29. The Top 5 and 10 Largest Manufacturers of Antigen Rapid Test in the World: Market Share by Antigen Rapid Test Revenue in 2021
Figure 30. Global Antigen Rapid Test Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 31. Global Antigen Rapid Test Sales Market Share by Type (2017-2028)
Figure 32. Global Antigen Rapid Test Revenue Market Share by Type (2017-2028)
Figure 33. Global Antigen Rapid Test Sales Market Share by Application (2017-2028)
Figure 34. Global Antigen Rapid Test Revenue Market Share by Application (2017-2028)
Figure 35. North America Antigen Rapid Test Sales Market Share by Type (2017-2028)
Figure 36. North America Antigen Rapid Test Revenue Market Share by Type (2017-2028)
Figure 37. North America Antigen Rapid Test Sales Market Share by Application (2017-2028)
Figure 38. North America Antigen Rapid Test Revenue Market Share by Application (2017-2028)
Figure 39. North America Antigen Rapid Test Sales Share by Country (2017-2028)
Figure 40. North America Antigen Rapid Test Revenue Share by Country (2017-2028)
Figure 41. United States Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 42. Canada Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 43. Europe Antigen Rapid Test Sales Market Share by Type (2017-2028)
Figure 44. Europe Antigen Rapid Test Revenue Market Share by Type (2017-2028)
Figure 45. Europe Antigen Rapid Test Sales Market Share by Application (2017-2028)
Figure 46. Europe Antigen Rapid Test Revenue Market Share by Application (2017-2028)
Figure 47. Europe Antigen Rapid Test Sales Share by Country (2017-2028)
Figure 48. Europe Antigen Rapid Test Revenue Share by Country (2017-2028)
Figure 49. Germany Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 50. France Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 51. U.K. Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 52. Italy Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 53. Russia Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 54. Asia Pacific Antigen Rapid Test Sales Market Share by Type (2017-2028)
Figure 55. Asia Pacific Antigen Rapid Test Revenue Market Share by Type (2017-2028)
Figure 56. Asia Pacific Antigen Rapid Test Sales Market Share by Application (2017-2028)
Figure 57. Asia Pacific Antigen Rapid Test Revenue Market Share by Application (2017-2028)
Figure 58. Asia Pacific Antigen Rapid Test Sales Share by Region (2017-2028)
Figure 59. Asia Pacific Antigen Rapid Test Revenue Share by Region (2017-2028)
Figure 60. China Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 61. Japan Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 62. South Korea Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 63. India Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 64. Australia Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 65. China Taiwan Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 66. Indonesia Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 67. Thailand Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 68. Malaysia Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 69. Latin America Antigen Rapid Test Sales Market Share by Type (2017-2028)
Figure 70. Latin America Antigen Rapid Test Revenue Market Share by Type (2017-2028)
Figure 71. Latin America Antigen Rapid Test Sales Market Share by Application (2017-2028)
Figure 72. Latin America Antigen Rapid Test Revenue Market Share by Application (2017-2028)
Figure 73. Latin America Antigen Rapid Test Sales Share by Country (2017-2028)
Figure 74. Latin America Antigen Rapid Test Revenue Share by Country (2017-2028)
Figure 75. Mexico Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 76. Brazil Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 77. Argentina Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 78. Colombia Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 79. Middle East and Africa Antigen Rapid Test Sales Market Share by Type (2017-2028)
Figure 80. Middle East and Africa Antigen Rapid Test Revenue Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Antigen Rapid Test Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Antigen Rapid Test Revenue Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Antigen Rapid Test Sales Share by Country (2017-2028)
Figure 84. Middle East and Africa Antigen Rapid Test Revenue Share by Country (2017-2028)
Figure 85. Turkey Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 86. Saudi Arabia Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 87. UAE Antigen Rapid Test Revenue (2017-2028) & (US$ Million)
Figure 88. Antigen Rapid Test Value Chain
Figure 89. Antigen Rapid Test Production Process
Figure 90. Channels of Distribution
Figure 91. Distributors Profiles
Figure 92. Bottom-up and Top-down Approaches for This Report
Figure 93. Data Triangulation
Figure 94. Key Executives Interviewed